ARTICLE | Company News
Atrix, Immune Network deal
August 12, 2002 7:00 AM UTC
IMMFF received non-exclusive access to ATRX's preclinical data related to dapsone, an antimicrobial and anti-inflammatory therapeutic. ATRX is in Phase III testing of its Atrisone topical dapsone for...